Clinical Characteristics of Patients Included in Study
Patient no. | Age (y) | Sex | Altered mental status or working memory deficit | New focal neurologic findings | Seizure | Duration of symptoms before presentation (wk) | Duration of symptom onset to 18F-FDG PET/CT (wk) | Duration between MRI and 18F-FDG PET/CT (d) | Type of 18F-FDG PET/CT scanner |
1 | 33 | F | Yes | Yes | Yes | 2 | 2 | 2 | GE RX |
2 | 20 | F | Yes | Yes | Yes | 3 | 3 | 13 | GE RX |
3 | 57 | F | Yes | Yes | Yes | 12 | 12 | 6 | GE RX |
4 | 21 | F | Yes | Yes | Yes | 1 | 1 | 1 | GE RX |
5 | 7 | M | Yes | Yes | Yes | 1 | 1 | 24 | GE RX |
6 | 67 | M | Yes | Yes | Yes | 8 | 8 | 11 | GE RX |
7 | 59 | M | Yes | Yes | No | 4 | 4 | 10 | GE LS |
8 | 66 | F | Yes | Yes | No | 16 | 16 | 3 | GE RX |
9 | 65 | M | Yes | No | Yes | 8 | 8 | 0 | GE RX |
10 | 43 | M | Yes | Yes | Yes | 12 | 12 | 1 | GE LS |
11 | 70 | M | Yes | Yes | No | 1 | 0 | 3 | GE RX |
12 | 50 | F | Yes | Yes | Yes | 4 | 36 | 4 | Siemens |
13 | 33 | M | Yes | No | No | 0 | 0 | 7 | GE RX |
14 | 62 | M | Yes | Yes | No | 8 | 8 | 3 | GE RX |
15 | 18 | F | Yes | Yes | Yes | 0 | 0 | 2 | GE RX |
16 | 76 | M | Yes | Yes | No | 1 | 1 | 7 | GE LS |
17 | 61 | M | Yes | Yes | No | 8 | 8 | 1 | Siemens |
18 | 67 | M | Yes | Yes | No | 1 | 1 | 1 | GE RX |
19 | 22 | F | Yes | Yes | Yes | 8 | 8 | 7 | GE RX |
20 | 40 | M | Yes | Yes | Yes | 4 | 24 | 4 | GE RX |
21 | 72 | F | Yes | Yes | No | 5 | 12 | 1 | GE LS |
22 | 9 | M | Yes | No | No | 16 | 20 | 32 | GE RX |
23 | 46 | M | Yes | Yes | No | 4 | 4 | 0 | Siemens |